DT
DEEMA TARAZI
BROWNSTEIN HYATT FARBER SCHRECK, LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
32
last 3 years
Filings
88
13 agencies contacted
Activity
filings by quarter
Works on
Specific issues
IRA implementation. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, National Defense Authorization Act. Appropriations bills (FDA, Labor, HHS).
Recognizing pharmacists as providers within Medicare; The Equitable Community Access to Pharmacist Services Act (H.R.1770/S. 2477; Medicare reimbursement.
Health technology and Artificial Intelligence
Issues related to the pharmaceutical industry Issues related to Inflation Reduction Act Implementation H.R. 4818 Treat and Reduce Obesity Act
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutical products Implementation of the Inflation reduction Act Pharmaceutical innovation PBM policy issues S. 476/H.R.5547 The Maintaining Investments in New Innovations (MINI) Act Intellectual property Issues
Issues related to patient access, Issues related to pharmaceutical manufacturing, Issues related to Patent reform Implementation of Inflation Reduction Act of 2022 HELP Copays Act
Clients
Filing history
ELI LILLY AND COMPANY
RELX INC
NOVARTIS
CENCORA, INC.
NATIONAL ASSOCIATION OF CHILDREN'S HOSPITALS (N.A.C.H.)-CHA
MODERNA US INC.
PARTICLE HEALTH
KNOA PHARMA, FORMERLY REPORTED AS, PURDUE PHARMA L.P.
HARMONY BIOSCIENCES
LIFEPOINT HEALTH
NOVARTIS
ABBVIE